EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tet2-driven clonal hematopoiesis drives aortic aneurysm via macrophage-to-osteoclast–like differentiation

Jun Yonekawa, Yoshimitsu Yura, Junmiao Luo, Katsuhiro Kato, Shuta Ikeda, Yohei Kawai, Tomoki Hattori, Ryotaro Okamoto, Mari Kizuki, Emiri Miura-Yura, Keita Horitani, Kyung-Duk Min und 5 weitere

Journal of Clinical Investigation · 2026

DOI: 10.1172/jci198708 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Jun Yonekawa und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Hauptthemen laut MEDLINE: Clonal Hematopoiesis, DNA-Binding Proteins, Proto-Oncogene Proteins, Macrophages. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Science and Technology Agency, the Japan Foundation for Applied Enzymology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aortic aneurysms are age-linked aortic dilations that progress silently and carry high mortality rates following rupture. Immune cells are recognized drivers of aneurysm pathogenesis. Clonal hematopoiesis is an age-related expansion of somatically mutated hematopoietic stem cells that reshapes immune function and contributes to diverse age-associated diseases. However, its contribution to aneurysm pathogenesis remains unclear. In this study, targeted ultradeep sequencing of patient specimens revealed a high prevalence of clonal hematopoiesis–associated mutations that correlated with faster aneurysm expansion. Thus, we modeled clonal hematopoiesis by competitively transplanting ten-eleven translocation 2–deficient ( Tet2 -deficient) bone marrow into apoliprotein E–KO ( Apoe -KO) mice and induced aneurysms with angiotensin II. Mice with Tet2 clonal hematopoiesis developed significantly greater aortic dilation than did controls. Interestingly, Tet2 -deficient macrophages adopted an acid phosphatase 5, tartrate resistant (ACP5 + ), osteoclast-like state and produced more matrix metalloproteinase 9 (MMP9). Both genetic and pharmacological inhibition of osteoclast-like differentiation suppressed the Tet2-mediated aneurysmal growth in vivo. Thus, Tet2-driven clonal hematopoiesis accelerated aortic aneurysm progression through MMP9-producing, osteoclast-like macrophages and therefore represents a tractable therapeutic axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clonal HematopoiesisDNA-Binding ProteinsProto-Oncogene ProteinsMacrophagesCell DifferentiationOsteoclastsAortic AneurysmAnimalsDioxygenasesMiceHumansMatrix Metalloproteinase 9Mice, KnockoutMale

Stichwörter der Autor:innen

AgingCardiologyGenetic risk factorsHematopoietic stem cellsMacrophagesVascular biology

Substanzen

DioxygenasesDNA-Binding ProteinsTet2 protein, mouseProto-Oncogene ProteinsMatrix Metalloproteinase 9TET2 protein, humanMmp9 protein, mouse

Autor:innen und Institutionen

  • Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Division of Vascular and Endovascular Surgery, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Department of Vascular Surgery, Aichi Medical University, Nagakute, Japan.
  • Division of Diabetes, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Japan.
  • Department of Medicine II, Kansai Medical University, Osaka, Japan.
  • Department of Cardiovascular and Renal Medicine, Hyogo Medical University, Hyogo, Japan.

Förderung

  • Japan Society for the Promotion of Science
  • Japan Science and Technology Agency
  • the Japan Foundation for Applied Enzymology
  • Kowa Life Science Foundation
  • MSD Life Science Foundation, Public Interest Incorporated Foundation
  • Mitsubishi Foundation
  • Suzuken Memorial Foundation
  • The Hori Science and Arts Foundation

Zitieren

APA

Yonekawa, J., Yura, Y., Luo, J., Kato, K., Ikeda, S., Kawai, Y., Hattori, T., Okamoto, R., Kizuki, M., Miura-Yura, E., Horitani, K., Min, K. D., Emoto, T., Banno, H., Takefuji, M., Walsh, K., & Murohara, T. (2026). Tet2-driven clonal hematopoiesis drives aortic aneurysm via macrophage-to-osteoclast–like differentiation. Journal of Clinical Investigation. https://doi.org/10.1172/jci198708

Vancouver

Yonekawa J, Yura Y, Luo J, Kato K, Ikeda S, Kawai Y, et al. Tet2-driven clonal hematopoiesis drives aortic aneurysm via macrophage-to-osteoclast–like differentiation. Journal of Clinical Investigation. 2026. doi:10.1172/jci198708

BibTeX
@article{Yonekawa2026,
  author = {Yonekawa, Jun and Yura, Yoshimitsu and Luo, Junmiao and Kato, Katsuhiro and Ikeda, Shuta and Kawai, Yohei and Hattori, Tomoki and Okamoto, Ryotaro and Kizuki, Mari and Miura-Yura, Emiri and Horitani, Keita and Min, Kyung-Duk and Emoto, Takuo and Banno, Hiroshi and Takefuji, Mikito and Walsh, Kenneth and Murohara, Toyoaki},
  title = {Tet2-driven clonal hematopoiesis drives aortic aneurysm via macrophage-to-osteoclast–like differentiation},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  doi = {10.1172/jci198708}
}
Kostenlos starten →